Harvard 4th Annual Update in Neuro-Oncology 2024
2024 Course Overview
Harvard 4th Annual Update in Neuro-Oncology 2024 is a rapidly evolving multi-disciplinary field, which involves the medical, radiation, and surgical management of pediatric and adult patients with primary and metastatic tumors of the central nervous system (CNS) and peripheral nervous system (PNS). In addition, modern molecular neuropathology and neuroradiology concepts are essential for accurate diagnosis and classification. This three-day CME course, Annual Update in Neuro-Oncology, is designed to provide an international audience with a comprehensive review of the diagnosis and management of pediatric and adult patients with primary and metastatic CNS and PNS tumors and neurological complications of cancer. Our target audience will be the providers involved in the care of adult and pediatric neuro-oncology patients (oncologists, radiation oncologists, neurosurgeons, neurologists, neuroradiologists, and neuropathologists). The course will also be of high relevance to nurse practitioners, physician assistants, psychologists, pharmacists, and nurses.
Who Should Attend
- Specialty Physicians
- Physician Assistants
- Nurses
- Pharmacists
- Psychologists
Learning Objectives
Upon completion of this activity, participants will be able to:
- Define the role of molecular biomarkers in the accurate diagnosis and classification of pediatric and adult CNS and PNS tumors.
- Determine standard and novel treatment approaches to pediatric and adult CNS and PNS tumors.
- Recognize and manage neurological complications associated with new cancer therapies.
- Identify and manage long-term complications of CNS and PNS tumors and their treatment.
Wednesday, July 24, 2024
Welcome: Pediatric Neuro-Oncology Session
Scott Pomeroy, MD, PhD
Keynote: Targeted Therapy for Pediatric Low-Grade Glioma
Karen Wright, MD
WHO Classification, Pediatric CNS Tumors
Sanda Alexandrescu, MD
Advances in the Imaging of Pediatric Brain Tumors
Tina Young Poussaint, MD, FACR
Embryonal Tumors
Scott Pomeroy, MD, PhD
Break
Pediatric Low-Grade Gliomas
Susan Chi, MD
Pediatric High-Grade Gliomas
Mariella Filbin, MD, PhD
Ependymomas
Pratiti Bandopadhayay, MBBS, PhD
Live Q&A Session
Scott Pomeroy, MD, PhD
Break
Choroid Plexus Tumors
Viviana Benitez, MD
Pineal Tumors
Shannon MacDonald, MD
Germ Cell Tumors
Kee Kiat Yeo, MD
Neurofibromatosis
Scott Plotkin, MD, PhD
Von Hippel Lindau
Othon Iliopoulos, MD
Live Q&A Session
Scott Pomeroy, MD, PhD
Thursday, July 25, 2024
Welcome: Adult Neuro-Oncology
Bob Carter, MD, PhD
Keynote: CAR-T Cell Therapy for Glioblatoma
Bryan Choi, MD, PhD
Advances in Surgery for Brain Tumors
E. Antonio Chiocca, MD, PhD
Advances in Imaging for Brain Tumors
Pamela Schaefer, MD, FACR
Advances in Radiation for Brain Tumors
Helen Shih, MD
Live Question and Answer Session
Bob Carter, MD, PhD
Break
WHO Classification for Adult Gliomas
Maria Martinez—Lage Alvarez, MD
Gliomas, IDH-Mutant
​​​​​Nicolas Gonzalez Castro, MD, PhD
Gliomas, IDH-Wildtype
Isabel Arrillaga-Romany, MD, PhD
Advances in Experimental Therapies for Gliomas
David Reardon, MD
Break
Meningioma
Wenya Linda Bi, MD, PhD
CNS Lymphomas
Tracy Batchelor, MD, MPH
Pituitary Tumors
Pamela Jones, MD
Live Question & Answer Session
Bob Carter, MD, PhD
Adjourn
Bob Carter, MD, PhD
Friday, July 26, 2024
Welcome: Neurological Complications of Cancer
Patrick Wen, MD
Keynote: The Oncogenic Origins of Temporal Lobe Epilepsy
Sattar Khoshkhoo, MD
Metastases to the Brain
Priscilla Brastianos, MD
Metastases to the Leptomeninges
Jose Ricardo McFaline-Figueroa, MD, PhD
Metastases to the Epidural Space and Spinal Cord
John Chi, MD, MPH
Live Question and Answer Session
Patrick Wen, MD
Break
Paraneoplastic Neurological Syndromes
Eudocia Lee, MD, MPH
Common Neurological Complications in Cancer Patients
Nancy Wang, MD
Neurological Complications of Cancer Immunotherapies
Jorg Dietrich, MD, PhD
Managing Long-Term Survivors of CNS Tumors
Deborah Forst, MD
The Role of the Neuropsychologist in Neuro-Oncology
Michael Parsons, PhD, ABPP
Live Question and Answer Session
Patrick Wen, MD
Closing Statements
Tracy Batchelor, MD, MPH